Anti-apoptotic BCL2 family members, including BCL2, BCL-XL, and MCL1, suppress apoptosis and are upregulated in cancer cells, including leukemia cells, where their expression is associated with poor prognosis [24–26]. This evidence concerns the gene MCL1 and leukemia.